{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:31:48Z","timestamp":1793323908536,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI125704"],"award-info":[{"award-number":["R01AI125704"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI139690"],"award-info":[{"award-number":["R21AI139690"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI123920"],"award-info":[{"award-number":["R21AI123920"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI139087"],"award-info":[{"award-number":["R01AI139087"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA235533"],"award-info":[{"award-number":["CA235533"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>C. difficile<\/jats:italic> is a major cause of antibiotic-associated gastrointestinal infections. Two <jats:italic>C. difficile<\/jats:italic> exotoxins (TcdA and TcdB) are major virulence factors associated with these infections, and chondroitin sulfate proteoglycan 4 (CSPG4) is a potential receptor for TcdB, but its pathophysiological relevance and the molecular details that govern recognition remain unknown. Here, we determine the cryo-EM structure of a TcdB\u2013CSPG4 complex, revealing a unique binding site spatially composed of multiple discontinuous regions across TcdB. Mutations that selectively disrupt CSPG4 binding reduce TcdB toxicity in mice, while CSPG4-knockout mice show reduced damage to colonic tissues during <jats:italic>C. difficile<\/jats:italic> infections. We further show that bezlotoxumab, the only FDA approved anti-TcdB antibody, blocks CSPG4 binding via an allosteric mechanism, but it displays low neutralizing potency on many TcdB variants from epidemic hypervirulent strains due to sequence variations in its epitopes. In contrast, a CSPG4-mimicking decoy neutralizes major TcdB variants, suggesting a strategy to develop broad-spectrum therapeutics against TcdB.<\/jats:p>","DOI":"10.1038\/s41467-021-23878-3","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:03:07Z","timestamp":1624010587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6356-7683","authenticated-orcid":false,"given":"Peng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatim","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6630-1904","authenticated-orcid":false,"given":"Songhai","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3441-698X","authenticated-orcid":false,"given":"Liang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig B.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gerhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-4687","authenticated-orcid":false,"given":"Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1744-7293","authenticated-orcid":false,"given":"Min","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-7363","authenticated-orcid":false,"given":"Rongsheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"23878_CR1","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","volume":"382","author":"AY Guh","year":"2020","unstructured":"Guh, A. Y. et al. Trends in U.S. burden of clostridioides difficile infection and outcomes. N. Engl. J. Med. 382, 1320\u20131330 (2020).","journal-title":"N. Engl. J. Med."},{"key":"23878_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/MAJ.0b013e3181e939d8","volume":"340","author":"L Heinlen","year":"2010","unstructured":"Heinlen, L. & Ballard, J. D. Clostridium difficile infection. Am. J. Med. Sci. 340, 247\u2013252 (2010).","journal-title":"Am. J. Med. Sci."},{"key":"23878_CR3","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1093\/clinids\/18.Supplement_4.S265","volume":"18","author":"JG Bartlett","year":"1994","unstructured":"Bartlett, J. G. Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin. Infect. Dis. 18, S265\u2013S272 (1994).","journal-title":"Clin. Infect. Dis."},{"key":"23878_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/QCO.0b013e32818be71d","volume":"20","author":"EJ Kuijper","year":"2007","unstructured":"Kuijper, E. J., Van Dissel, J. T. & Wilcox, M. H. Clostridium difficile: changing epidemiology and new treatment options. Curr. Opin. Infect. Dis. 20, 376\u2013383 (2007).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"23878_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-micro-090816-093458","volume":"71","author":"K Aktories","year":"2017","unstructured":"Aktories, K., Schwan, C. & Jank, T. Clostridium difficile toxin biology. Annu. Rev. Microbiol. 71, 281\u2013307 (2017).","journal-title":"Annu. Rev. Microbiol."},{"key":"23878_CR6","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nature07822","volume":"458","author":"D Lyras","year":"2009","unstructured":"Lyras, D. et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458, 1176\u20131179 (2009).","journal-title":"Nature"},{"key":"23878_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijid.2006.04.003","volume":"11","author":"D Drudy","year":"2007","unstructured":"Drudy, D., Fanning, S. & Kyne, L. Toxin A-negative, toxin B-positive Clostridium difficile. Int J. Infect. Dis. 11, 5\u201310 (2007).","journal-title":"Int J. Infect. Dis."},{"key":"23878_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/cid\/ciw364","volume":"63","author":"SB Gupta","year":"2016","unstructured":"Gupta, S. B. et al. Antibodies to toxin B are protective against clostridium difficile infection recurrence. Clin. Infect. Dis. 63, 730\u2013734 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"23878_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa1602615","volume":"376","author":"MH Wilcox","year":"2017","unstructured":"Wilcox, M. H. et al. Bezlotoxumab for prevention of recurrent clostridium difficile infection. N. Engl. J. Med. 376, 305\u2013317 (2017).","journal-title":"N. Engl. J. Med."},{"key":"23878_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41594-019-0268-0","volume":"26","author":"P Chen","year":"2019","unstructured":"Chen, P. et al. Structure of the full-length Clostridium difficile toxin B. Nat. Struct. Mol. Biol. 26, 712\u2013719 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"23878_CR11","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/375500a0","volume":"375","author":"I Just","year":"1995","unstructured":"Just, I. et al. Glucosylation of rho proteins by clostridium difficile toxin B. Nature 375, 500\u2013503 (1995).","journal-title":"Nature"},{"key":"23878_CR12","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1074\/jbc.M114.612184","volume":"290","author":"JL Larabee","year":"2015","unstructured":"Larabee, J. L., Krumholz, A., Hunt, J. J., Lanis, J. M. & Ballard, J. D. Exposure of neutralizing epitopes in the carboxyl-terminal domain of TcdB is altered by a proximal hypervariable region. J. Biol. Chem. 290, 6975\u20136985 (2015).","journal-title":"J. Biol. Chem."},{"key":"23878_CR13","doi-asserted-by":"publisher","first-page":"e58634","DOI":"10.1371\/journal.pone.0058634","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity. PLoS ONE 8, e58634 (2013).","journal-title":"PLoS ONE"},{"key":"23878_CR14","doi-asserted-by":"crossref","unstructured":"Li, Z. H. et al. Ribotype classification of clostridioides difficile isolates is not predictive of the amino acid sequence diversity of the toxin virulence factors TcdA and TcdB. Front. Microbiol. 11, 1310 (2020).","DOI":"10.3389\/fmicb.2020.01310"},{"key":"23878_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s42003-020-1078-y","volume":"3","author":"E Shen","year":"2020","unstructured":"Shen, E. et al. Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B. Commun. Biol. 3, 347 (2020).","journal-title":"Commun. Biol."},{"key":"23878_CR16","doi-asserted-by":"publisher","first-page":"e1009181","DOI":"10.1371\/journal.ppat.1009181","volume":"16","author":"MJ Mansfield","year":"2020","unstructured":"Mansfield, M. J. et al. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B. PLoS Pathog. 16, e1009181 (2020).","journal-title":"PLoS Pathog."},{"key":"23878_CR17","doi-asserted-by":"publisher","first-page":"e1003523","DOI":"10.1371\/journal.ppat.1003523","volume":"9","author":"JM Lanis","year":"2013","unstructured":"Lanis, J. M., Heinlen, L. D., James, J. A. & Ballard, J. D. Clostridium difficile 027\/BI\/NAP1 encodes a hypertoxic and antigenically variable form of TcdB. PLoS Pathog. 9, e1003523 (2013).","journal-title":"PLoS Pathog."},{"key":"23878_CR18","doi-asserted-by":"publisher","first-page":"e1001061","DOI":"10.1371\/journal.ppat.1001061","volume":"6","author":"JM Lanis","year":"2010","unstructured":"Lanis, J. M., Barua, S. & Ballard, J. D. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. PLoS Pathog. 6, e1001061 (2010).","journal-title":"PLoS Pathog."},{"key":"23878_CR19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/infdis\/jis416","volume":"206","author":"AJ Marozsan","year":"2012","unstructured":"Marozsan, A. J. et al. Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies. J. Infect. Dis. 206, 706\u2013713 (2012).","journal-title":"J. Infect. Dis."},{"key":"23878_CR20","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1128\/AAC.04433-14","volume":"59","author":"LD Hernandez","year":"2015","unstructured":"Hernandez, L. D. et al. Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling. Antimicrob. Agents Chemother. 59, 1052\u20131060 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"23878_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature19799","volume":"538","author":"L Tao","year":"2016","unstructured":"Tao, L. et al. Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. Nature 538, 350\u2013355 (2016).","journal-title":"Nature"},{"key":"23878_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/cr.2014.169","volume":"25","author":"P Yuan","year":"2015","unstructured":"Yuan, P. et al. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B. Cell Res. 25, 157\u2013168 (2015).","journal-title":"Cell Res."},{"key":"23878_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/febs.14681","volume":"286","author":"P Chen","year":"2019","unstructured":"Chen, P., Tao, L., Liu, Z., Dong, M. & Jin, R. Structural insight into Wnt signaling inhibition by Clostridium difficile toxin B. FEBS J. 286, 874\u2013881 (2019).","journal-title":"FEBS J."},{"key":"23878_CR24","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.aar1999","volume":"360","author":"P Chen","year":"2018","unstructured":"Chen, P. et al. Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. Science 360, 664\u2013669 (2018).","journal-title":"Science"},{"key":"23878_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1023\/A:1025731428581","volume":"31","author":"WB Stallcup","year":"2002","unstructured":"Stallcup, W. B. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. 31, 423\u2013435 (2002).","journal-title":"J. Neurocytol."},{"key":"23878_CR26","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1096\/fj.201801670R","volume":"33","author":"E Tamburini","year":"2019","unstructured":"Tamburini, E. et al. Structural deciphering of the NG2\/CSPG4 proteoglycan multifunctionality. FASEB J. 33, 3112\u20133128 (2019).","journal-title":"FASEB J."},{"key":"23878_CR27","doi-asserted-by":"crossref","unstructured":"Henkel, D. et al. Receptor binding domains of TcdB from Clostridioides difficile for chondroitin sulfate proteoglycan-4 and frizzled proteins are functionally independent and additive. Toxins (Basel) 12, 736 (2020).","DOI":"10.3390\/toxins12120736"},{"key":"23878_CR28","doi-asserted-by":"crossref","unstructured":"Lopez-Urena, D. et al. Toxin B variants from Clostridium difficile strains VPI 10463 and NAP1\/027 share similar substrate profile and cellular intoxication kinetics but use different host cell entry factors. Toxins 11, 348 (2019).","DOI":"10.3390\/toxins11060348"},{"key":"23878_CR29","doi-asserted-by":"crossref","unstructured":"Mileto, S. J. et al. Clostridioides difficile infection damages colonic stem cells via TcdB, impairing epithelial repair and recovery from disease. Proc Natl Acad Sci USA 117, 8064\u20138073 (2020).","DOI":"10.1073\/pnas.1915255117"},{"key":"23878_CR30","doi-asserted-by":"publisher","first-page":"17290","DOI":"10.1074\/jbc.M117.806687","volume":"292","author":"P Gupta","year":"2017","unstructured":"Gupta, P. et al. Functional defects in Clostridium difficile TcdB toxin uptake identify CSPG4 receptor-binding determinants. J. Biol. Chem. 292, 17290\u201317301 (2017).","journal-title":"J. Biol. Chem."},{"key":"23878_CR31","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.1021\/acs.analchem.6b02240","volume":"88","author":"CB Gutierrez","year":"2016","unstructured":"Gutierrez, C. B. et al. Developing an acidic residue reactive and sulfoxide-containing MS-cleavable homobifunctional cross-linker for probing protein-protein interactions. Anal. Chem. 88, 8315\u20138322 (2016).","journal-title":"Anal. Chem."},{"key":"23878_CR32","doi-asserted-by":"publisher","first-page":"002212","DOI":"10.1074\/mcp.M110.002212","volume":"10","author":"A Kao","year":"2011","unstructured":"Kao, A. et al. Development of a novel cross-linking strategy for fast and accurate identification of cross-linked peptides of protein complexes. Mol. Cell Proteom. 10, 002212 (2011).","journal-title":"Mol. Cell Proteom."},{"key":"23878_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1021\/acs.analchem.7b04431","volume":"90","author":"C Yu","year":"2018","unstructured":"Yu, C. & Huang, L. Cross-linking mass spectrometry: an emerging technology for interactomics and structural biology. Anal. Chem. 90, 144\u2013165 (2018).","journal-title":"Anal. Chem."},{"key":"23878_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1126\/science.279.5350.509","volume":"279","author":"A Hall","year":"1998","unstructured":"Hall, A. Rho GTPases and the actin cytoskeleton. Science 279, 509\u2013514 (1998).","journal-title":"Science"},{"key":"23878_CR35","doi-asserted-by":"publisher","first-page":"e00551","DOI":"10.1128\/mBio.00551-15","volume":"6","author":"GP Carter","year":"2015","unstructured":"Carter, G. P. et al. Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections. MBio 6, e00551 (2015).","journal-title":"MBio"},{"key":"23878_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1242\/jcs.112.6.905","volume":"112","author":"KA Grako","year":"1999","unstructured":"Grako, K. A., Ochiya, T., Barritt, D., Nishiyama, A. & Stallcup, W. B. PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. J. Cell Sci. 112, 905\u2013915 (1999).","journal-title":"J. Cell Sci."},{"key":"23878_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.anaerobe.2017.10.006","volume":"48","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Anaerobe 48, 249\u2013256 (2017).","journal-title":"Anaerobe"},{"key":"23878_CR38","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1074\/jbc.M114.560748","volume":"289","author":"P Orth","year":"2014","unstructured":"Orth, P. et al. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography. J. Biol. Chem. 289, 18008\u201318021 (2014).","journal-title":"J. Biol. Chem."},{"key":"23878_CR39","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fmicb.2020.01310","volume":"11","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Ribotype classification of Clostridioides difficile isolates is not predictive of the amino acid sequence diversity of the toxin virulence factors TcdA and TcdB. Front. Microbiol. 11, 1310 (2020).","journal-title":"Front. Microbiol."},{"key":"23878_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00418-006-0184-3","volume":"126","author":"N Terada","year":"2006","unstructured":"Terada, N. et al. Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines. Histochem. Cell Biol. 126, 483\u2013490 (2006).","journal-title":"Histochem. Cell Biol."},{"key":"23878_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev.physiol.70.113006.100646","volume":"73","author":"DW Powell","year":"2011","unstructured":"Powell, D. W., Pinchuk, I. V., Saada, J. I., Chen, X. & Mifflin, R. C. Mesenchymal cells of the intestinal lamina propria. Annu. Rev. Physiol. 73, 213\u2013237 (2011).","journal-title":"Annu. Rev. Physiol."},{"key":"23878_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10254-004-0033-5","volume":"152","author":"I Just","year":"2004","unstructured":"Just, I. & Gerhard, R. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharm. 152, 23\u201347 (2004).","journal-title":"Rev. Physiol. Biochem. Pharm."},{"key":"23878_CR43","doi-asserted-by":"crossref","unstructured":"Peng, Z. et al. Designed ankyrin repeat protein (DARPin) neutralizers of TcdB from Clostridium difficile ribotype 027. mSphere 4, e00596-19 (2019).","DOI":"10.1128\/mSphere.00596-19"},{"key":"23878_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature14264","volume":"519","author":"MR Gardner","year":"2015","unstructured":"Gardner, M. R. et al. AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges. Nature 519, 87\u201391 (2015).","journal-title":"Nature"},{"key":"23878_CR45","doi-asserted-by":"publisher","first-page":"35222","DOI":"10.1074\/jbc.M703138200","volume":"282","author":"T Jank","year":"2007","unstructured":"Jank, T., Giesemann, T. & Aktories, K. Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding. J. Biol. Chem. 282, 35222\u201335231 (2007).","journal-title":"J. Biol. Chem."},{"key":"23878_CR46","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1128\/IAI.02316-14","volume":"83","author":"S Li","year":"2015","unstructured":"Li, S. et al. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis. Infect. Immun. 83, 502\u2013513 (2015).","journal-title":"Infect. Immun."},{"key":"23878_CR47","doi-asserted-by":"crossref","unstructured":"Yang, G. L. et al. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium. BMC Microbiol. 8, 192 (2008).","DOI":"10.1186\/1471-2180-8-192"},{"key":"23878_CR48","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1073\/pnas.1915542117","volume":"117","author":"C Gutierrez","year":"2020","unstructured":"Gutierrez, C. et al. Structural dynamics of the human COP9 signalosome revealed by cross-linking mass spectrometry and integrative modeling. Proc. Natl Acad. Sci. USA 117, 4088\u20134098 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"23878_CR49","doi-asserted-by":"publisher","first-page":"8315","DOI":"10.1021\/acs.analchem.6b02240","volume":"88","author":"CB Gutierrez","year":"2016","unstructured":"Gutierrez, C. B. et al. Developing an acidic residue reactive and sulfoxide-containing MS-cleavable homobifunctional cross-linker for probing protein protein interactions. Anal. Chem. 88, 8315\u20138322 (2016).","journal-title":"Anal. Chem."},{"key":"23878_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013362 (2009).","journal-title":"Nat. Methods"},{"key":"23878_CR51","doi-asserted-by":"publisher","first-page":"10301","DOI":"10.1021\/acs.analchem.6b03148","volume":"88","author":"C Yu","year":"2016","unstructured":"Yu, C. et al. Developing a multiplexed quantitative cross-linking mass spectrometry platform for comparative structural analysis of protein complexes. Anal. Chem. 88, 10301\u201310308 (2016).","journal-title":"Anal. Chem."},{"key":"23878_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"23878_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"23878_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"23878_CR55","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"23878_CR56","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"23878_CR57","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","volume":"135","author":"X Chen","year":"2008","unstructured":"Chen, X. et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135, 1984\u20131992 (2008).","journal-title":"Gastroenterology"},{"key":"23878_CR58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-4939-6361-4_9","volume":"1476","author":"AN Edwards","year":"2016","unstructured":"Edwards, A. N. & McBride, S. M. Isolating and purifying Clostridium difficile spores. Methods Mol. Biol. 1476, 117\u2013128 (2016).","journal-title":"Methods Mol. Biol."},{"key":"23878_CR59","doi-asserted-by":"crossref","unstructured":"Edwards, A. N. et al. Chemical and stress resistances of Clostridium difficile spores and vegetative cells. Front. Microbiol. 7, 1698 (2016).","DOI":"10.3389\/fmicb.2016.01698"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23878-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23878-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T13:11:46Z","timestamp":1669986706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-23878-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["23878"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-23878-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A provisional patent application has been filed by The Regents of the University of California on the use of the structural information described in this manuscript to prevent and\/or treat CDI, with P.C. and R.J. as inventors. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3748"}}